METHOD OF ANTIOXIDANT STATUS CORRECTION IN TREATING ERYTHEMATOUS-TELANGIECTATIC AND PAPULOPUSTULAR FORMS OF ROSACEA OF MILD AND MODERATE SEVERITY Russian patent published in 2021 - IPC A61K31/194 A61K31/455 A61K31/525 A61K31/708 A61P17/10 A61P39/06 

FIELD: medicine.

SUBSTANCE: invention relates to the field of medicine, namely to a method of correction of antioxidant status in treatment of patients with erythematous-telangiectatic and papular-pustular forms of rosacea of light and medium severity, including a daily oral administration of a medicinal agent of antioxidant action against a background of external application of Azelaic acid, cream 20% or gel 15%, 2 times a day in the morning and in the evening, differing by the fact that as a medicinal agent of antioxidant action patients take Cytoflavin 2 tablets 2 times a day in the morning and in evening 30 minutes before meals for 21 days.

EFFECT: technical result consists in correction of antioxidant status in treating erythematous-telangiectatic patients and papulo-pustular forms of rosacea of mild and moderate severity with no side effects of pharmacotherapy and improved overall psychosomatic status of the patient, wider range of possible indications for prescribing the preparation Cytoflavin, reducing the length of the course of pharmacological correction of lipid peroxidation processes to 21 days compared to the prototype.

1 cl, 2 tbl, 2 ex